|
1
|
Karamysheva AF: Mechanisms of
angiogenesis. Biochemistry (Mosc). 73:751–762. 2008. View Article : Google Scholar
|
|
2
|
Lawall H, Bramlage P and Amann B:
Treatment of peripheral arterial disease using stem and progenitor
cell therapy. J Vasc Surg. 53:445–453. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gimble JM, Bunnell BA and Guilak F: Human
adipose-derived cells: an update on the transition to clinical
translation. Regen Med. 7:225–235. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kalka C, Masuda H, Takahashi T, Kalka-Moll
WM, Silver M, Kearney M, Li T, Isner JM and Asahara T:
Transplantation of ex vivo expanded endothelial progenitor cells
for therapeutic neovascularization. Proc Natl Acad Sci USA.
97:3422–3427. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Asahara T, Murohara T, Sullivan A, Silver
M, van der Zee R, Li T, Witzenbichler B, Schatteman G and Isner JM:
Isolation of putative progenitor endothelial cells for
angiogenesis. Science. 275:964–967. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Carmeliet P: Mechanisms of angiogenesis
and arteriogenesis. Nat Med. 6:389–395. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Artavanis-Tsakonas S, Rand MD and Lake RJ:
Notch signaling: cell fate control and signal integration in
development. Science. 284:770–776. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Roca C and Adams RH: Regulation of
vascular morphogenesis by Notch signaling. Genes Dev. 21:2511–2524.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Leslie JD, Ariza-McNaughton L, Bermange
AL, McAdow R, Johnson SL and Lewis J: Endothelial signalling by the
Notch ligand Delta-like 4 restricts angiogenesis. Development.
134:839–844. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Phng LK and Gerhardt H: Angiogenesis: a
team effort coordinated by notch. Dev Cell. 16:196–208. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Scehnet JS, Jiang W, Kumar SR, et al:
Inhibition of Dll4-mediated signaling induces proliferation of
immature vessels and results in poor tissue perfusion. Blood.
109:4753–4760. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Noguera-Troise I, Daly C, Papadopoulos NJ,
Coetzee S, Boland P, Gale NW, Lin HC, Yancopoulos GD and Thurston
G: Blockade of Dll4 inhibits tumour growth by promoting
non-productive angiogenesis. Nature. 444:1032–1037. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ridgway J, Zhang G, Wu Y, et al:
Inhibition of Dll4 signalling inhibits tumour growth by
deregulating angiogenesis. Nature. 444:1083–1087. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu L, Wen T, Zheng XY, Yang DG, Zhao SP,
Xu DY and Lü GH: Remnant-like particles accelerate endothelial
progenitor cells senescence and induce cellular dysfunction via an
oxidative mechanism. Atherosclerosis. 202:405–414. 2009. View Article : Google Scholar
|
|
15
|
Chen JJ and Zhou SH: Mesenchymal stem
cells overexpressing MiR-126 enhance ischemic angiogenesis via the
AKT/ERK-related pathway. Cardiol J. 18:675–681. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Urbich C, Aicher A, Heeschen C, Dernbach
E, Hofmann WK, Zeiher AM and Dimmeler S: Soluble factors released
by endothelial progenitor cells promote migration of endothelial
cells and cardiac resident progenitor cells. J Mol Cell Cardiol.
39:733–742. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang F, Zhu X, Hu XQ, et al: Mesenchymal
stem cells modified with miR-126 release angiogenic factors and
activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis
and cell survival. Int J Mol Med. 31:484–492. 2013.PubMed/NCBI
|
|
18
|
Murohara T: Angiogenesis and
vasculogenesis for therapeutic neovascularization. Nagoya J Med
Sci. 66:1–7. 2003.PubMed/NCBI
|
|
19
|
Deuse T, Peter C, Fedak PW, et al:
Hepatocyte growth factor or vascular endothelial growth factor gene
transfer maximizes mesenchymal stem cell-based myocardial salvage
after acute myocardial infarction. Circulation. 120(Suppl 11):
S247–S254. 2009. View Article : Google Scholar
|
|
20
|
Suchting S, Freitas C, le Noble F,
Benedito R, Bréant C, Duarte A and Eichmann A: The Notch ligand
Delta-like 4 negatively regulates endothelial tip cell formation
and vessel branching. Proc Natl Acad Sci USA. 104:3225–3230. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lobov IB, Renard RA, Papadopoulos N, Gale
NW, Thurston G, Yancopoulos GD and Wiegand SJ: Delta-like ligand 4
(Dll4) is induced by VEGF as a negative regulator of angiogenic
sprouting. Proc Natl Acad Sci USA. 104:3219–3224. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Al Haj Zen A, Oikawa A, Bazan-Peregrino M,
Meloni M, Emanueli C and Madeddu P: Inhibition of
delta-like-4-mediated signaling impairs reparative angiogenesis
after ischemia. Circ Res. 107:283–293. 2010.PubMed/NCBI
|
|
23
|
Miriuka SG, Rao V, Peterson M, Tumiati L,
Delgado DH, Mohan R, Ramzy D, Stewart D, Ross HJ and Waddell TK:
mTOR inhibition induces endothelial progenitor cell death. Am J
Transplant. 6:2069–2079. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Maiese K, Chong ZZ, Shang YC and Hou J:
FoxO proteins: cunning concepts and considerations for the
cardiovascular system. Clin Sci (Lond). 116:191–203. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lemaitre V, Dabo AJ and D’Armiento J:
Cigarette smoke components induce matrix metalloproteinase-1 in
aortic endothelial cells through inhibition of mTOR signaling.
Toxicol Sci. 123:542–549. 2011. View Article : Google Scholar
|
|
26
|
Humar R, Kiefer FN, Berns H, Resink TJ and
Battegay EJ: Hypoxia enhances vascular cell proliferation and
angiogenesis in vitro via rapamycin (mTOR)-dependent signaling.
FASEB J. 16:771–780. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chan SM, Weng AP, Tibshirani R, Aster JC
and Utz PJ: Notch signals positively regulate activity of the mTOR
pathway in T-cell acute lymphoblastic leukemia. Blood. 110:278–286.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shutter JR, Scully S, Fan W, Richards WG,
Kitajewski J, Deblandre GA, Kintner CR and Stark KL: Dll4, a novel
Notch ligand expressed in arterial endothelium. Genes Dev.
14:1313–1318. 2000.PubMed/NCBI
|
|
29
|
Hellström M, Phng LK, Hofmann JJ, et al:
Dll4 signalling through Notch1 regulates formation of tip cells
during angiogenesis. Nature. 445:776–780. 2007.PubMed/NCBI
|
